19 Apr 2023 --- Royal DSM is entering into negotiations to purchase Adare Biome from its parent company, Adare Pharma Solutions, for an enterprise value of €275 million (US$301.2 million). The move will expand the company’s human health and animal nutrition offerings. DSM states that the acquisition would allow the company to bring some of Adare Biome’s signature postbiotic products to the growing gut health and digestive health segments.
